Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Danaher Corporation

DHR-PA•NYSE
Healthcare
Medical - Diagnostics & Research
$1841.01
$0.00(0.00%)
U.S. Market opens in 17h 23m

Danaher Corporation (DHR-PA) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio41.10
EPS (TTM)$7.88
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

DHR-PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR-PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 41.10 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

https://www.danaher.com
202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

780,000 Employees
IPO DateFeb 27, 2019
CountryUS

Frequently Asked Questions